|Articles|March 2, 2004
- Pharmaceutical Technology-03-02-2004
- Volume 28
- Issue 3
Pharmaceutical Pricing and Healthcare Access
Author(s)Jill Wechsler
Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.
Advertisement
Articles in this issue
over 22 years ago
The Effect of Buffers on Protein Conformational Stabilityover 22 years ago
Packaging Helps Protect Temperature-Sensitive Productsover 22 years ago
Resealed Erythrocytes: A Reviewover 22 years ago
Pharma Industry Drives Innovation in Barrier/Isolation Designover 22 years ago
Connecting Clinical Trial Management to Pharmaceutical Manufacturingover 22 years ago
March 2003over 22 years ago
Stakes Getting Higher for ContractorsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Peptide Compounding Vote Raises New Questions for Drug Developers
3
Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates
4
What Jideytro's Approval Means for Drug Developers
5